Table 1 Clinicopathological characteristics of the 43 MB patient’s cohort
n | Percent (%) | ||
|---|---|---|---|
Gender | |||
Male | 27 | 62.8 | |
Female | 16 | 37.2 | |
Age group | |||
Infant | 5 | 11.6 | |
Child | 17 | 39.5 | |
Adolescent | 5 | 11.6 | |
Adult | 16 | 37.2 | |
Molecular subgroup | |||
WNT | 6 | 14 | |
SHH | 21 | 48.8 | |
Group 3 | 4 | 9.3 | |
Group 4 | 12 | 27.9 | |
Histology | |||
Anaplastic/large cells | 2 | 4.7 | |
Classic | 30 | 69.8 | |
Extensive nodularity | 3 | 7 | |
Nodular/desmoplastic | 8 | 18.6 | |
Surgical resection | |||
Partial | 20 | 46.5 | |
Total | 23 | 53.5 | |
Metastasis at diagnosis | |||
Absent | 33 | 76.7 | |
Present | 9 | 20.9 | |
TERTstatus* | |||
WT | 15 | 34.9 | |
Mutated | 9 | 20.9 | |
NA | 19 | 44.2 | |
Vital status | |||
Alive | 21 | 48.8 | |
Deceased (cancer) | 10 | 23.3 | |
Deceased (other causes) | 9 | 20.9 | |
NA | 3 | 7 | |